annual cash & cash equivalents:
$1.70B+$489.50M(+40.53%)Summary
- As of today (May 19, 2025), UTHR annual cash & cash equivalents is $1.70 billion, with the most recent change of +$489.50 million (+40.53%) on December 31, 2024.
- During the last 3 years, UTHR annual cash & cash equivalents has risen by +$802.40 million (+89.67%).
- UTHR annual cash & cash equivalents is now at all-time high.
Performance
UTHR Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.90B+$202.70M(+11.94%)Summary
- As of today (May 19, 2025), UTHR quarterly cash & cash equivalents is $1.90 billion, with the most recent change of +$202.70 million (+11.94%) on March 31, 2025.
- Over the past year, UTHR quarterly cash & cash equivalents has increased by +$648.40 million (+51.81%).
- UTHR quarterly cash & cash equivalents is now at all-time high.
Performance
UTHR quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
UTHR Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.5% | +51.8% |
| 3 y3 years | +89.7% | +133.6% |
| 5 y5 years | +129.8% | +117.1% |
UTHR Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +89.7% | at high | +138.9% |
| 5 y | 5-year | at high | +129.8% | at high | +183.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
UTHR Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.90B(+11.9%) |
| Dec 2024 | $1.70B(+40.5%) | $1.70B(+9.2%) |
| Sep 2024 | - | $1.55B(+14.6%) |
| Jun 2024 | - | $1.36B(+8.3%) |
| Mar 2024 | - | $1.25B(+3.6%) |
| Dec 2023 | $1.21B(+25.6%) | $1.21B(+9.0%) |
| Sep 2023 | - | $1.11B(+3.8%) |
| Jun 2023 | - | $1.07B(-8.3%) |
| Mar 2023 | - | $1.16B(+21.0%) |
| Dec 2022 | $961.20M(+7.4%) | $961.20M(-0.6%) |
| Sep 2022 | - | $966.80M(+21.6%) |
| Jun 2022 | - | $795.20M(-2.2%) |
| Mar 2022 | - | $813.30M(-9.1%) |
| Dec 2021 | $894.80M(+21.1%) | $894.80M(-1.5%) |
| Sep 2021 | - | $908.50M(-3.6%) |
| Jun 2021 | - | $942.20M(+13.2%) |
| Mar 2021 | - | $832.30M(+12.7%) |
| Dec 2020 | $738.70M(+0.0%) | $738.70M(+10.2%) |
| Sep 2020 | - | $670.20M(-2.2%) |
| Jun 2020 | - | $685.40M(-21.7%) |
| Mar 2020 | - | $875.20M(+18.5%) |
| Dec 2019 | $738.40M(+10.3%) | $738.40M(+2.6%) |
| Sep 2019 | - | $719.70M(-18.3%) |
| Jun 2019 | - | $881.30M(+11.5%) |
| Mar 2019 | - | $790.60M(+18.1%) |
| Dec 2018 | $669.20M(-5.1%) | $669.20M(+2.0%) |
| Sep 2018 | - | $656.00M(-12.1%) |
| Jun 2018 | - | $745.90M(-20.0%) |
| Mar 2018 | - | $932.70M(+32.3%) |
| Dec 2017 | $705.10M(-31.1%) | $705.10M(-33.9%) |
| Sep 2017 | - | $1.07B(+6.1%) |
| Jun 2017 | - | $1.01B(-10.4%) |
| Mar 2017 | - | $1.12B(+9.7%) |
| Dec 2016 | $1.02B(+23.0%) | $1.02B(+7.3%) |
| Sep 2016 | - | $953.00M(+13.8%) |
| Jun 2016 | - | $837.50M(-1.1%) |
| Mar 2016 | - | $846.80M(+1.8%) |
| Dec 2015 | $831.80M(+109.2%) | $831.80M(+8.7%) |
| Sep 2015 | - | $765.21M(+200.8%) |
| Jun 2015 | - | $254.36M(-40.4%) |
| Mar 2015 | - | $426.51M(+7.2%) |
| Dec 2014 | $397.70M(+39.9%) | $397.70M(-20.0%) |
| Sep 2014 | - | $497.29M(+92.0%) |
| Jun 2014 | - | $259.05M(-37.4%) |
| Mar 2014 | - | $413.79M(+45.6%) |
| Dec 2013 | $284.26M(+84.5%) | $284.26M(-11.8%) |
| Sep 2013 | - | $322.23M(-6.2%) |
| Jun 2013 | - | $343.55M(+31.1%) |
| Mar 2013 | - | $262.13M(+70.2%) |
| Dec 2012 | $154.03M(-5.3%) | $154.03M(-41.5%) |
| Sep 2012 | - | $263.43M(+67.8%) |
| Jun 2012 | - | $157.01M(+0.2%) |
| Mar 2012 | - | $156.67M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $162.68M(-35.5%) | $162.68M(-52.7%) |
| Sep 2011 | - | $343.98M(+7.1%) |
| Jun 2011 | - | $321.12M(+11.1%) |
| Mar 2011 | - | $288.96M(+14.6%) |
| Dec 2010 | $252.16M(+151.3%) | $252.16M(+20.0%) |
| Sep 2010 | - | $210.19M(-26.4%) |
| Jun 2010 | - | $285.41M(+50.3%) |
| Mar 2010 | - | $189.96M(+89.3%) |
| Dec 2009 | $100.35M(-22.5%) | $100.35M(-25.4%) |
| Sep 2009 | - | $134.50M(+0.7%) |
| Jun 2009 | - | $133.52M(+35.1%) |
| Mar 2009 | - | $98.85M(-23.6%) |
| Dec 2008 | $129.45M(-7.1%) | $129.45M(+19.9%) |
| Sep 2008 | - | $107.97M(-13.9%) |
| Jun 2008 | - | $125.33M(-29.4%) |
| Mar 2008 | - | $177.65M(+27.5%) |
| Dec 2007 | $139.32M(+53.0%) | $139.32M(+89.5%) |
| Sep 2007 | - | $73.54M(-9.7%) |
| Jun 2007 | - | $81.48M(+20.1%) |
| Mar 2007 | - | $67.85M(-25.5%) |
| Dec 2006 | $91.07M(+31.6%) | $91.07M(+87.8%) |
| Sep 2006 | - | $48.50M(-32.0%) |
| Jun 2006 | - | $71.32M(-18.6%) |
| Mar 2006 | - | $87.62M(+26.7%) |
| Dec 2005 | $69.18M(-16.2%) | $69.18M(-2.6%) |
| Sep 2005 | - | $71.02M(+25.6%) |
| Jun 2005 | - | $56.53M(-31.7%) |
| Mar 2005 | - | $82.81M(+0.3%) |
| Dec 2004 | $82.59M(+20.5%) | $82.59M(-4.4%) |
| Sep 2004 | - | $86.38M(+16.0%) |
| Jun 2004 | - | $74.48M(+8.7%) |
| Mar 2004 | - | $68.52M(-0.1%) |
| Dec 2003 | $68.56M(-44.1%) | $68.56M(-20.7%) |
| Sep 2003 | - | $86.44M(-5.1%) |
| Jun 2003 | - | $91.07M(-0.2%) |
| Mar 2003 | - | $91.24M(-25.6%) |
| Dec 2002 | $122.66M(+403.2%) | $122.66M(-8.3%) |
| Sep 2002 | - | $133.81M(+760.7%) |
| Jun 2002 | - | $15.55M(-25.0%) |
| Mar 2002 | - | $20.73M(-15.0%) |
| Dec 2001 | $24.37M(-87.9%) | $24.37M(-71.8%) |
| Sep 2001 | - | $86.48M(-47.0%) |
| Jun 2001 | - | $163.29M(-11.0%) |
| Mar 2001 | - | $183.40M(-8.7%) |
| Dec 2000 | $200.94M(+998.0%) | $200.94M(-10.4%) |
| Sep 2000 | - | $224.29M(+136.0%) |
| Jun 2000 | - | $95.04M(-7.5%) |
| Mar 2000 | - | $102.79M(+461.7%) |
| Dec 1999 | $18.30M(+169.1%) | $18.30M(+215.5%) |
| Sep 1999 | - | $5.80M(+28.9%) |
| Jun 1999 | - | $4.50M(-70.8%) |
| Mar 1999 | - | $15.40M |
| Dec 1998 | $6.80M | - |
FAQ
- What is United Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for United Therapeutics?
- What is United Therapeutics annual cash & cash equivalents year-on-year change?
- What is United Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for United Therapeutics?
- What is United Therapeutics quarterly cash & cash equivalents year-on-year change?
What is United Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of UTHR is $1.70B
What is the all time high annual cash & cash equivalents for United Therapeutics?
United Therapeutics all-time high annual cash & cash equivalents is $1.70B
What is United Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, UTHR annual cash & cash equivalents has changed by +$489.50M (+40.53%)
What is United Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of UTHR is $1.90B
What is the all time high quarterly cash & cash equivalents for United Therapeutics?
United Therapeutics all-time high quarterly cash & cash equivalents is $1.90B
What is United Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, UTHR quarterly cash & cash equivalents has changed by +$648.40M (+51.81%)